Logo image of CME

CME GROUP INC (CME) Stock Analyst Earnings Estimates

NASDAQ:CME - Nasdaq - US12572Q1058 - Common Stock - Currency: USD

235.28  -0.64 (-0.27%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
CME revenue by date.CME revenue by date.
4.997B
-1.38%
7.218B
44.45%
10.854B
50.38%
6.176B
-43.10%
6.344B
2.72%
6.652B
4.85%
6.797B
2.18%
7.096B
4.40%
EBITDA
YoY % growth
CME ebitda by date.CME ebitda by date.
3.338B
1.61%
5.577B
67.10%
9.064B
62.52%
4.4B
-51.45%
4.53B
2.95%
4.712B
4.02%
4.958B
5.22%
5.29B
6.70%
EBIT
YoY % growth
CME ebit by date.CME ebit by date.
2.952B
4.68%
5.214B
76.63%
8.711B
67.06%
4.143B
-52.44%
4.279B
3.28%
4.486B
4.84%
4.771B
6.35%
5.171B
8.38%
Operating Margin
CME operating margin by date.CME operating margin by date.
59.08%72.24%80.25%67.08%67.45%67.44%70.19%72.87%
EPS
YoY % growth
CME eps by date.CME eps by date.
6.69
-0.59%
7.98
19.28%
9.34
17.04%
10.32
10.50%
10.51
1.88%
10.96
4.28%
11.69
6.62%
12.73
8.86%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
2.49
5.26%
2.58
3.14%
2.60
1.49%
2.67
-0.21%
2.55
2.07%
2.70
4.75%
2.71
4.32%
2.75
2.70%
2.65
4.14%
Revenue
Q2Q % growth
1.541B
7.07%
1.547B
3.97%
1.567B
2.25%
1.615B
1.93%
1.592B
3.31%
1.638B
5.88%
1.647B
5.11%
1.69B
4.64%
1.672B
5.03%
EBITDA
Q2Q % growth
1.077B
-53.02%
1.086B
-48.68%
1.102B
-50.24%
1.155B
-49.88%
1.094B
1.58%
1.152B
6.08%
1.164B
5.63%
1.213B
5.02%
1.15B
5.12%
EBIT
Q2Q % growth
1.013B
-47.79%
1.057B
-47.95%
1.066B
-47.88%
1.105B
-46.12%
1.058B
4.44%
1.129B
6.81%
1.127B
5.72%
1.14B
3.17%
1.112B
5.10%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
2.68
19.11%
2.680.00-0.04%
Q2 2024
Q2Q % growth
2.56
11.30%
2.560.000.05%
Q1 2024
Q2Q % growth
2.50
3.31%
2.480.020.99%
Q4 2023
Q2Q % growth
2.37
23.44%
2.310.062.81%
Q3 2023
Q2Q % growth
2.25
13.64%
2.240.010.25%
Q2 2023
Q2Q % growth
2.30
16.75%
2.220.083.47%
Q1 2023
Q2Q % growth
2.42
14.69%
2.400.020.87%
Q4 2022
Q2Q % growth
1.92
15.66%
1.900.021.05%
Q3 2022
Q2Q % growth
1.98
23.75%
1.960.021.23%
Q2 2022
Q2Q % growth
1.97
20.12%
1.950.020.82%
Q1 2022
Q2Q % growth
2.11
17.88%
2.020.094.40%
Q4 2021
Q2Q % growth
1.66
19.42%
1.660.000.19%
Q3 2021
Q2Q % growth
1.60
15.94%
1.580.021.56%
Q2 2021
Q2Q % growth
1.64
0.61%
1.620.021.08%
Q1 2021
Q2Q % growth
1.79
-23.18%
1.760.031.52%
Q4 2020
Q2Q % growth
1.39
-8.55%
1.380.010.64%
Q3 2020
Q2Q % growth
1.38
-27.37%
1.42-0.04-3.13%
Q2 2020
Q2Q % growth
1.63
-7.39%
1.64-0.01-0.31%
Q1 2020
Q2Q % growth
2.33
43.83%
2.250.083.33%
Q4 2019
Q2Q % growth
1.52 1.56-0.04-2.48%
Q3 2019
Q2Q % growth
1.90 1.780.126.68%
Q2 2019
Q2Q % growth
1.76 1.78-0.02-1.27%
Q1 2019
Q2Q % growth
1.62 1.620.000.26%
CME Yearly EPS VS EstimatesCME Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
1.584B
18.43%
1.595B-10.6M-0.66%
Q2 2024
Q2Q % growth
1.533B
12.67%
1.549B-16.5M-1.07%
Q1 2024
Q2Q % growth
1.488B
3.21%
1.496B-8.1M-0.54%
Q4 2023
Q2Q % growth
1.439B
-39.01%
1.443B-3.7M-0.26%
Q3 2023
Q2Q % growth
1.338B
-30.10%
1.355B-17.2M-1.27%
Q2 2023
Q2Q % growth
1.36B
-10.75%
1.354B6.2M0.46%
Q1 2023
Q2Q % growth
1.442B
1.54%
1.406B35.6M2.53%
Q4 2022
Q2Q % growth
2.36B
94.22%
1.224B1.136B92.81%
Q3 2022
Q2Q % growth
1.914B
52.42%
1.233B681M55.23%
Q2 2022
Q2Q % growth
1.524B
22.75%
1.258B266.1M21.15%
Q1 2022
Q2Q % growth
1.42B
10.55%
1.328B91.7M6.91%
Q4 2021
Q2Q % growth
1.215B
7.57%
1.182B33.1M2.80%
Q3 2021
Q2Q % growth
1.256B
13.71%
1.163B92.7M7.97%
Q2 2021
Q2Q % growth
1.242B
2.24%
1.184B57.6M4.86%
Q1 2021
Q2Q % growth
1.284B
-20.63%
1.27B14.2M1.12%
Q4 2020
Q2Q % growth
1.13B
-12.16%
1.11B19.6M1.77%
Q3 2020
Q2Q % growth
1.104B
-13.54%
1.105B-700K-0.06%
Q2 2020
Q2Q % growth
1.214B
-4.58%
1.207B7.4M0.61%
Q1 2020
Q2Q % growth
1.618B
37.17%
1.509B109M7.22%
Q4 2019
Q2Q % growth
1.286B 1.172B114M9.73%
Q3 2019
Q2Q % growth
1.277B 1.282B-4.7M-0.37%
Q2 2019
Q2Q % growth
1.273B 1.293B-20.3M-1.57%
Q1 2019
Q2Q % growth
1.18B 1.202B-22.4M-1.86%
CME Yearly Revenue VS EstimatesCME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0.05% 0% 3.22%
Revenue0% 0.06% -0.21% 1.53%